These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 29698925

  • 21. Quality of care in breast cancer centers: results of benchmarking by the German Cancer Society and German Society for Breast Diseases.
    Kowalski C, Ferencz J, Brucker SY, Kreienberg R, Wesselmann S.
    Breast; 2015 Apr; 24(2):118-23. PubMed ID: 25515645
    [Abstract] [Full Text] [Related]

  • 22. Psycho-oncological care in certified cancer centres--a nationwide analysis in Germany.
    Singer S, Dieng S, Wesselmann S.
    Psychooncology; 2013 Jun; 22(6):1435-7. PubMed ID: 22855347
    [Abstract] [Full Text] [Related]

  • 23. Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
    van Dam PA, Tomatis M, Marotti L, Heil J, Mansel RE, Rosselli Del Turco M, van Dam PJ, Casella D, Bassani LG, Danei M, Denk A, Egle D, Emons G, Friedrichs K, Harbeck N, Kiechle M, Kimmig R, Koehler U, Kuemmel S, Maass N, Mayr C, Prové A, Rageth C, Regolo L, Lorenz-Salehi F, Sarlos D, Singer C, Sohn C, Staelens G, Tinterri C, Audisio R, Ponti A, eusomaDB Working Group.
    Eur J Cancer; 2017 Nov; 85():15-22. PubMed ID: 28881247
    [Abstract] [Full Text] [Related]

  • 24. Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients.
    Schwentner L, Van Ewijk R, Kurzeder C, Hoffmann I, König J, Kreienberg R, Blettner M, Wöckel A.
    Eur J Cancer; 2013 Feb; 49(3):553-63. PubMed ID: 22959469
    [Abstract] [Full Text] [Related]

  • 25. The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients.
    Jacke CO, Albert US, Kalder M.
    BMC Cancer; 2015 Oct 19; 15():734. PubMed ID: 26481452
    [Abstract] [Full Text] [Related]

  • 26. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    Sinha AK, Patel JR, Shen Y, Ueno NT, Giordano SH, Tripathy D, Lopez DS, Barcenas CH.
    PLoS One; 2017 Oct 19; 12(1):e0170081. PubMed ID: 28085940
    [Abstract] [Full Text] [Related]

  • 27. Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer?
    Ebner F, Hancke K, Blettner M, Schwentner L, Wöckel A, Kreienberg R, Janni W, van Ewijk R.
    Clin Breast Cancer; 2015 Aug 19; 15(4):e189-95. PubMed ID: 25913904
    [Abstract] [Full Text] [Related]

  • 28. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
    Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofstädter F, Lindberg P, Gerstenhauer M, Schüler S, Treeck O, Ortmann O.
    J Cancer Res Clin Oncol; 2015 Dec 19; 141(12):2229-40. PubMed ID: 26253629
    [Abstract] [Full Text] [Related]

  • 29. A Tale of Two Hospitals: Effect of Access to Care Through a Safety Net Hospital on Adjuvant Therapy, Imaging Compliance and 5-Year Survival Rates Compared to the University Hospital Served by the Same Breast Cancer Clinical Teams.
    Mootz AR, Ozcan BB, Polat DS, Acevedo Z, Xi Y, Unni N, Nwachukwu C, Dogan BE.
    Acad Radiol; 2024 Jul 19; 31(7):2728-2738. PubMed ID: 38365491
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P, Barbieri V, Genovesi D.
    Eur J Surg Oncol; 2011 Oct 19; 37(10):876-82. PubMed ID: 21824742
    [Abstract] [Full Text] [Related]

  • 31. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T, von Minckwitz G, Bengtsson NO, Brandberg Y, Wallberg B, Fornander T, Mlineritsch B, Schmatloch S, Singer CF, Steger G, Egle D, Karlsson E, Carlsson L, Loibl S, Untch M, Hellström M, Johansson H, Anderson H, Malmström P, Gnant M, Greil R, Möbus V, Bergh J, Swedish Breast Cancer Group (SweBCG), the German Breast Group (GBG), and the Austrian Breast & Colorectal Cancer Study Group (ABCSG).
    JAMA; 2016 Nov 08; 316(18):1888-1896. PubMed ID: 27825007
    [Abstract] [Full Text] [Related]

  • 32. Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.
    Wöckel A, Kurzeder C, Geyer V, Novasphenny I, Wolters R, Wischnewsky M, Kreienberg R, Varga D.
    Breast; 2010 Apr 08; 19(2):120-7. PubMed ID: 20117932
    [Abstract] [Full Text] [Related]

  • 33. Influence of adherence with guideline-driven recommendations on survival in women operated for breast cancer: Real-life evidence from Italy.
    Corrao G, Rea F, Di Felice E, Di Martino M, Davoli M, Merlino L, Carle F, De Palma R, “Monitoring and assessing diagnostic-therapeutic paths (MAP)” of the Italian Ministry of Health.
    Breast; 2020 Oct 08; 53():51-58. PubMed ID: 32629156
    [Abstract] [Full Text] [Related]

  • 34. Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle.
    Wolters R, Schwentner L, Regierer A, Wischnewsky M, Kreienberg R, Wöckel A.
    Breast Cancer Res Treat; 2012 Feb 08; 131(3):925-31. PubMed ID: 22080246
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?
    Varga D, Wischnewsky M, Atassi Z, Wolters R, Geyer V, Strunz K, Kreienberg R, Woeckel A.
    Oncology; 2010 Feb 08; 78(3-4):189-95. PubMed ID: 20414007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.